Long-Acting Specialty Drugs Force Pharma Marketers to Abandon the Chronic Disease Rulebook

A breakthrough HIV immunotherapy that could suppress the virus for years with a single infusion represents more than a clinical milestone. It marks the arrival of a new category of ultra-long-acting specialty therapies that will force healthcare marketers to abandon the chronic disease playbook they

Episode metadata supplied by the publisher feed · Published May 12, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Long-Acting Specialty Drugs Force Pharma Marketers to Abandon the Chronic Disease Rulebook

0:00 14:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 1nessAgency Insights?

This episode is 14 minutes long.

When was this 1nessAgency Insights episode published?

This episode was published on May 12, 2026.

Can I download this 1nessAgency Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!